Adopting a Framework for Rapid Real-World Data Analyses in Safety Signal Assessment

被引:0
|
作者
Wang, Lu [1 ]
Golchin, Negar [2 ]
von Klot, Stephanie [3 ]
Salinas, Claudia A. [4 ]
Manlik, Katrin [5 ]
Patadia, Vaishali [6 ]
Miller, Mary K. [7 ]
Asubonteng, Julius [8 ]
McDermott, Rachel [9 ]
Barberio, Julie [10 ]
Gipson, Geoffrey [1 ]
机构
[1] Pharmaceut Co Johnson & Johnson, Janssen Res & Dev LLC, 200 Tournament Dr, Horsham, PA 19044 USA
[2] BMS, New York, NY USA
[3] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[4] Eli Lilly & Co, Indianapolis, IN USA
[5] Bayer AG, Berlin, Germany
[6] Amgen Inc, Thousand Oaks, CA USA
[7] Genentech Inc, South San Francisco, CA USA
[8] Regeneron, Tarrytown, NY USA
[9] Shionogi, Osaka, Japan
[10] Sanofi, Cambridge, MA USA
关键词
Real-world data (RWD); Safety signal assessment; Pharmacovigilance; Transcelerate; Minimal protocol; Rapid data analysis;
D O I
10.1007/s43441-024-00694-7
中图分类号
R-058 [];
学科分类号
摘要
The expanding availability of real-world data (RWD) has led to an increase in both the interest and possibilities for using this information in postmarketing safety analyses and signal management. While there is enormous potential value from the safety insights generated through RWD, the analysis preparation, execution, and communication required to reliably deliver the evidence can be time consuming. Since the safety signal assessment process is a regulated and timebound process, any supporting RWD analyses require a rapid turnaround of well-designed and informative results. To address this challenge, a TransCelerate BioPharma working group was formed and developed a framework to help teams responsible for safety signal assessment overcome the challenges of working with RWD rapidly to deliver analyses within regulatory timelines. Here, a previously performed safety assessment was evaluated within the context of the developed framework to illustrate how the framework may be adopted in practice.
引用
收藏
页码:1014 / 1022
页数:9
相关论文
共 50 条
  • [21] METHOTDOLOGICAL DIFFICULTIES OF COMPLIANCE ANALYSES BASED ON REAL-WORLD DATA
    Andriska, P.
    Komaromi, T.
    Frigyesy, R.
    Salfer, B.
    VALUE IN HEALTH, 2015, 18 (07) : A692 - A692
  • [22] Translating real-world evidence/real-world data
    Ravenstijn, Paulien
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [23] Safety assessment of esomeprazole: real-world adverse event signal mining and analysis based on FAERS database
    Wang, Bojing
    Huang, Shu
    Li, Shiqi
    Deng, Yaqi
    Li, Ziyan
    Wang, Yizhou
    Shi, Xiaomin
    Zhang, Wei
    Shi, Lei
    Tang, Xiaowei
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [24] ASSESSMENT OF REAL-WORLD DATA SOURCES AND A HYBRID APPROACH IN REAL-WORLD EVIDENCE GENERATION USING UNHARMONIZED DATA SOURCES
    Toh, K. C.
    Goh, C. H.
    Goh, V
    Dong, Z.
    Dumpala, L. S.
    Maity, S.
    Wu, J. Y.
    Kleinman, N.
    Lee, Y.
    VALUE IN HEALTH, 2024, 27 (06) : S407 - S407
  • [25] Real-world data for efficient health technology assessment
    Hall, Peter S.
    EUROPEAN JOURNAL OF CANCER, 2017, 79 : 235 - 237
  • [26] Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment
    Huang, Jing
    Su, Anping
    Yang, Jing
    Zhuang, Wei
    Li, Zhihui
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [27] REAL-WORLD DATA
    STROCK, JM
    POLICY REVIEW, 1993, 63 : 96 - 96
  • [28] Use of Routinely Collected "Real-world" Data for the Postlicensure Safety Assessment of Vaccination During Pregnancy
    Regan, Annette K.
    Rowe, Stacey L.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2025, 44 (02) : S108 - S110
  • [29] Real-world data: A relevant component in the framework of scientific evidence
    Canonica, Giorgio W.
    Del Moro, Lorenzo
    Costanzo, Giovanni
    Nappi, Emanuele
    Paoletti, Giovanni
    ASIA PACIFIC ALLERGY, 2023, 13 (01) : 40 - 43
  • [30] A framework for understanding selection bias in real-world healthcare data
    Kundu, Ritoban
    Shi, Xu
    Morrison, Jean
    Barrett, Jessica
    Mukherjee, Bhramar
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2024, 187 (03) : 606 - 635